Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
INVITE is a research-oriented joint venture between Bayer, the TU Dortmund University, and the Heinrich Heine University Düsseldorf, focused on developing innovative production technologies for the chemical and pharmaceutical industries. The company specializes in modular "Plug & Produce" manufacturing, continuous processing, and advanced drug delivery systems. By bridging the gap between academic research and industrial application, INVITE provides a platform for testing new process technologies in a GMP-like environment. Their work primarily supports the optimization of manufacturing efficiency and flexibility for both small molecules and biologics. As a key player in the development of Industry 4.0 standards for the life sciences, INVITE facilitates the transition from batch to continuous manufacturing.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on INVITE.